Outcomes Insights

What Outcomes Insights does

Outcomes Insights is a private healthcare research firm headquartered in Calabasas, California, founded in 2003, that delivers custom research engagements to pharmaceutical and life sciences clients and patient advocacy organizations. The company operates through two practice areas: Market Research and Strategy (commercial assessment, innovation strategy, product development and brand planning, brand performance) and Real World Evidence Generation (observational-data analysis in epidemiology, health services research, and health economics). Its revenue model is professional services, with quote-based, custom-tailored engagements and no publicly disclosed pricing or standardized product offering.

The firm's technology stack centers on a proprietary in-house software platform for analyzing real-world data, built around a publicly available Generalized Data Model designed to create analysis-ready datasets from observational sources. The platform is positioned as flexible and reproducible versus canned or black-box alternatives. Outcomes Insights demonstrates particular depth with U.S. Medicare-linked datasets (SEER-Medicare, USRDS, 5% Medicare sample), electronic health records, and UK-based CPRD data. Complementary tooling includes a SEER-Medicare Publication Tracker. Methodologies span choice modeling (adaptive conjoint, simple conjoint, discrete choice), MaxDiff, driver analysis, Q-Sort, segmentation, behavioral science analyses, and custom chart audits for hospital and office data.

Go-to-market is sales-led and direct-only, with no channel partners. Distribution relies on the company website, academic and medical conference presentations, peer-reviewed publications, and patient-advocacy partnerships that generate visibility and credibility. The firm holds EU-U.S. Data Privacy Framework, UK Extension, Swiss-U.S. DPF, and CCPA compliance certifications, enabling cross-border data handling. The core team of four to five people includes Sherry (Managing Partner, Research and Strategy), Mark (President, RWE Generation), Ryan (Lead Developer, RWE Generation), and Julie, operating as a boutique consultancy with no disclosed external funding or parent company.

Name

Outcomes Insights

Legal name

Outcomes Insights, Inc

Website

https://outins.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

1–10 employees

Short description

Outcomes Insights is a Calabasas, California-based boutique healthcare research firm founded in 2003 that delivers custom market research, commercial strategy, and real-world evidence generation services to pharmaceutical companies and patient advocacy groups using a proprietary software platform and a Generalized Data Model.

Ownership category

akta.pro rank

Product category

Healthcare Research and Real-World Evidence Services

NAICS

Marketing Research and Public Opinion Polling (541910), Scientific Research and Development Services (5417)

SIC

Services-Management Consulting Services (8742), Services-Health Services (8000)

akta.pro primary industry

Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)

akta.pro secondary industries

Clinical & Claims Data Integration for Population Health (payer-provider data fusion) (HLACAHAI), Cost of Care, Spend Analytics & Financial Performance Management (HLACAHAJ), Provider Performance, Network Analytics & Attribution (HLACAHAF)

Keywords

• Healthcare market research
• Real world evidence
• Commercial strategy consulting
• Observational data analysis
• Biomedical informatics

Headquarters

HQ city

Agoura Hills

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Market Research and Strategy Consulting: Custom market research engagements including commercial assessment, innovation strategy, product development, brand planning, and brand performance analysis for pharmaceutical and healthcare clients
2. Real World Evidence Generation: Research services analyzing observational data, including SEER-Medicare data analysis, USRDS data, 5% Medicare sample, electronic health records, and proprietary datasets from health plans and providers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Outcomes Insights is a healthcare research and consulting firm that conducts custom market research, commercial strategy, and real-world evidence generation for pharmaceutical, biotech, and patient advocacy clients. Engagements span opportunity assessment, innovation strategy, product development, brand planning, and brand performance, delivered through a proprietary in-house software platform and publicly available Generalized Data Model applied to SEER-Medicare, USRDS, Medicare 5% sample, CPRD (UK), and electronic health record datasets.

Product overview

Outcomes Insights offers a suite of healthcare research services organized into two practice areas: market research and commercial strategy, and real world evidence generation. The company's core offering includes proprietary in-house software that leverages decades of real-world data analysis experience. This software platform provides capabilities for epidemiology, health services research, and health economics analysis. The company has also developed a publicly available data model (The Generalized Data Model for clinical research) and specialized software for creating analysis-ready datasets from observational data. Together, these products enable customizable research without canned approaches or black-box solutions.

Differentiator

Problem solved

Functional benefit

Products and services

• Market Research and Commercial Strategy Custom market research and commercial strategy consulting for pharmaceutical, biotech, and healthcare clients. Engagements cover opportunity assessment, due diligence, market sizing and validation, pipeline prioritization, franchise strategy, asset optimization, scenario planning, product development and brand planning (performance requirements, value proposition, patient journey, buying process, competitive landscape, positioning, pricing, revenue models), brand performance tracking, concept and messaging optimization, launch tracking and KPIs, and customer insights.
• Real World Evidence (RWE) Generation Real-world evidence generation services analyzing observational data sources including SEER-Medicare linked data, USRDS data, the Medicare 5% sample, CPRD (UK), electronic health records, and proprietary datasets from health plans and providers. Work spans epidemiology, health services research, and health economics using the firm's proprietary in-house software platform and Generalized Data Model.
• In-House Software Platform Proprietary software platform used by Outcomes Insights to analyze real-world data in epidemiology, health services research, and health economics. Provides flexible, reproducible creation of analysis-ready datasets from observational data sources; underpins the firm's RWE Generation service offering.
• Generalized Data Model (publicly available) Publicly available generalized data model for clinical research that enables standardized analysis of healthcare data across different sources and studies, with emphasis on flexibility and reproducibility.

Quantifiable outcome

• Prioritized potential indications for myelofibrosis treatment leading with use in first-line JAK2 inhibitor-naive patients
• +4 more outcomes

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• BreastCancer.orgcoreStrategic or Co-development Partner · 1 January 2021Partnership to characterize breast cancer patients' awareness and understanding of medical marijuana in managing cancer pain and treatment side effects. Recruited 612 breast cancer patients through BCO community. Generated ASCO presentations, abstracts, and pending manuscript publication.
• COALA-TminorStrategic or Co-development Partner · 1 January 2021Patient advocacy group partnership for breast cancer research collaboration.
• Amanda HempminorStrategic or Co-development Partner · 1 January 2021Patient advocacy partnership for breast cancer cannabis research study.
• Glaucoma Research FoundationcoreStrategic or Co-development Partner · 1 January 2021Partnership to determine the impact of glaucoma on patients and caregivers as well as identify their information and support needs. Conducted 10-minute online survey with over 1500 patients and 60 caregivers. Generated editorial supplements, audio news release, infographic, and poster presentations.
• National Headache FoundationcoreStrategic or Co-development Partner · 1 January 2021Partnership to highlight experiences of people with migraine disease, trade-offs made to manage disease with current therapies, and impact on daily life. Conducted survey with over 1000 migraine sufferers. Generated NHF website content, influencer engagement, Facebook Live event, and DemandMoreForMigraine.com campaign.
• Pulmonary Fibrosis FoundationcoreStrategic or Co-development Partner · 1 January 2015Research collaboration to characterize the patient journey of interstitial lung disease as patients seek diagnosis. Research was conducted with members of the PFF and Inspire Online Community. Documented significant delays in diagnosis and diagnostic errors. Presented at PFF annual meeting 2015.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Evidera (PPD): Evidera is a dedicated real-world evidence and health economics/outcomes research (HEOR) services business serving pharma and biotech. Like Outcomes Insights, it generates RWE from observational data for commercial and clinical decisions, but at significantly greater scale.
• Trinity Life Sciences: Trinity Life Sciences is a pharma-focused market research and commercial strategy firm offering opportunity assessment, pipeline prioritization, and patient journey work — the same market-research-and-strategy half of Outcomes Insights' practice.
• Prescient Healthcare Group: Prescient is a pharma market research and competitive intelligence firm that competes for the same commercial strategy, patient journey, and launch-tracking engagements Outcomes Insights pursues.
• Charles River Associates - Life Sciences: CRA's Life Sciences practice provides management consulting in commercial strategy, pricing, and HEOR for pharma and biotech, overlapping with Outcomes Insights' market-research-and-strategy engagements.

Emerging players

• Aetion: Aetion is an RWE analytics platform company that partners with health systems and regulators to generate real-world evidence. It overlaps with Outcomes Insights in observational-data analysis but is software-led rather than custom-services-led.
• Flatiron Health: Flatiron Health is an oncology-focused real-world data and evidence company, originally built on EHR data. It competes where Outcomes Insights' oncology RWE work is most concentrated.

Broad incumbents

• ICON plc: ICON is a global clinical research and RWE provider with HEOR and real-world data capabilities. It competes for outsourced pharma research, though at much larger scale and across the clinical trial continuum.
• ZS Associates: ZS Associates is a large pharma-focused consulting firm operating in commercial strategy, market research, and real-world evidence. It overlaps directly with the strategy side of Outcomes Insights' offering for larger pharma accounts.
• IQVIA: IQVIA is the largest healthcare data, analytics, and RWE provider globally, operating overlapping claims/EHR-linked data analysis and HEOR services. Outcomes Insights competes for a slice of pharma RWE work where clients want a more boutique, custom-engagement model.

Others

• Definitive Healthcare: Definitive Healthcare provides commercial intelligence and analytics on healthcare providers, payors, and biopharma companies. It is adjacent to Outcomes Insights' market-research practice as a complementary data and insights vendor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/mark_danese

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Outcomes Insights